PCN75 - BUDGET IMPACT MODEL OF SUBCUTANEOUS TRASTUZUMAB COMPARED WITH INTRAVENOUS TRASTUZUMAB ON THE TREATMENT OF HER-2 POSITIVE BREAST CANCER IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.157
https://www.valueinhealthjournal.com/article/S1098-3015(18)33457-0/fulltext
Section Title :
Section Order :
926
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33457-0&doi=10.1016/j.jval.2018.09.157